Gene Solutions Study Finds Preterm-Birth Signals in Routine triSure NIPT Data
Sep 25, 2026
Singapore, September 25: Gene Solutions, a global biotechnology company providing precision cell-free DNA solutions through multi-omics and artificial intelligence to improve pregnancy care, cancer detection and precision medicine, today announced the publication of a study showing the potential to assess the risk of spontaneous preterm birth from cell-free DNA fragmentomic signals already present in routine first-trimester non-invasive prenatal testing (NIPT) data.
Read More ..